Filed: 8/4/2026ACC: 0001193125-26-332000
📋 What this filing means
MEDICXI VENTURES MANAGEMENT (JERSEY) LTD filed this quarterly 13F‑HR report disclosing 3 equity positions with a total reported market value of $177.42M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
3
Positions
$177.42M
Total AUM (reported)
12.71M
Total Shares
Allocation by class
COM$102.57M57.8%
ORDINARY SHARES$74.85M42.2%
Portfolio Concentration
Top 3$177.42M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 12.71M
Sole
Full voting authority
12.71M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole3
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings3
Rows:
PHATHOM PHARMACEUTICALS INC
SOLEShares7.46M
TypeSH
Market value$80.99M
45.65%
Sole
7.46M
Shared
0.00
None
0.00
NEWAMSTERDAM PHARMA COMPANY
SOLEShares2.21M
TypeSH
Market value$74.85M
42.19%
Sole
2.21M
Shared
0.00
None
0.00
AURA BIOSCIENCES INC
SOLEShares3.04M
TypeSH
Market value$21.58M
12.16%
Sole
3.04M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
PHATHOM PHARMACEUTICALS INCSOLE | COM | 7.46M | SH | $80.99M 45.65% | 7.46M | 0.00 | 0.00 |
NEWAMSTERDAM PHARMA COMPANYSOLE | ORDINARY SHARES | 2.21M | SH | $74.85M 42.19% | 2.21M | 0.00 | 0.00 |
AURA BIOSCIENCES INCSOLE | COM | 3.04M | SH | $21.58M 12.16% | 3.04M | 0.00 | 0.00 |